Sentence examples for therapeutics group from inspiring English sources

We have also just brought in a therapeutics group to pursue drug development for the first time.

The announcement says the capital will be used to "accelerate customer growth, continue funding its expanding therapeutics group, and invest in its crowdsourced genetic research platform".

Titers of IgG against a modified ApoB-100 peptide (p244 sequence corresponding to the amino acids 3144 3163 of ApoB-100) were measured with a commerically available ELISA kit (Ark Therapeutics Group Inc., London, UK).

This could be particularly important for the basal subtype given the general lack of effective therapeutics for this group of breast cancer patients.

Given the possibility that a proportion of human non-small cell lung cancers arise from SOX2 upregulation, this and future mouse models will be useful in testing existing and new therapeutics for this group of patients.

ARM divides the emerging market to four sub-groups: therapeutics and devices (56 %), tools (19 %), tissue banks (13 %) and services (12%%).

Stage 2 evaluated 6 therapeutics combinations, including groups B1 (hot pack plus active range of motion [ROM]), B2 (B1 plus ischemic compression), B3 (B2 plus transcutaneous electric nerve stimulation [TENS]), B4 (B1 plus stretch with spray), B5 (B4 plus TENS), and B6 (B1 plus interferential current and myofascial release).

This study was conducted by members of the Committee of Latin America on the Therapeutics of Inhibitor Groups (CLOTTING) (http://www.clotting.org).org

Personal healthcare has the goal to deliver specific targeted therapeutics to patient groups stratified based on predictive genetic or transcriptional markers.

The Committee of Latin America on the Therapeutics of Inhibitor Groups conducted a survey of its member country representatives on key aspects of haemophilia treatment in 10 countries.

The results of this search included therapeutic substances with a previously described therapeutic effect in DR, including a group of therapeutics belonging to the class of angiogenesis inhibitors (including bevacizumab), which are currently either in initial phases of clinical applications or being investigated in clinical trials (Table 4).